Volume 46, Issue 1 pp. 132-140

Quality of Life of People with Epilepsy in Iran, the Gulf, and Near East

Gus A. Baker

Gus A. Baker

University Department of Neurosciences, Walton Centre for Neurology and Neurosurgery

Search for more papers by this author
Ann Jacoby

Ann Jacoby

Department of Primary Care, University of Liverpool, Liverpool, United Kingdom

Search for more papers by this author
Joanne Gorry

Joanne Gorry

Department of Primary Care, University of Liverpool, Liverpool, United Kingdom

Search for more papers by this author
Julie Doughty

Julie Doughty

Centre for Health Service Research, University of Newcastle Upon Tyne, United Kingdom

Search for more papers by this author
Veronica Ellina

Veronica Ellina

GlaxoSmithKline, Cyprus

Search for more papers by this author
SIGN Group

SIGN Group

University Department of Neurosciences, Walton Centre for Neurology and Neurosurgery

Search for more papers by this author
First published: 11 January 2005
Citations: 82
Address correspondence and reprint requests to Dr. G.A. Baker at University Department of Neurosciences, Walton Centre for Neurology and Neurosurgery, Lower Lane, Liverpool L9 7LJ, U.K. E-mail [email protected]

Abstract

Summary: Purpose: To study the impact of epilepsy and its treatment on the quality of life of people living in Iran and in countries in the Gulf and Near East.

Methods: Clinical, demographic, and psychosocial details were collected through the use of a self-completed questionnaire distributed to patients attending hospital outpatient clinics.

Results: Data were collected from 3,889 people with epilepsy from 10 countries. More than 40% of all respondents had frequent seizures, and reported levels of side effects from medication were high, the most commonly reported being nervousness, headaches, and tiredness. A significant number of respondents reported changing their medications because of side effects or poor seizure control. Respondents reported that epilepsy and its treatment had a significant impact on a number of different aspects of their daily lives. A significant number of respondents felt stigmatized by their epilepsy. Reported health status was reduced when compared with that of people without epilepsy, particularly for physical and social functioning and energy and vitality, as assessed by using a generic health status measure, the SF-36.

Conclusions: This is the largest study to date documenting the impact of epilepsy and its treatment in Iran, the Gulf, and Near East regions. Differences were found between the quality-of-life profiles of respondents in this study and those who participated in an earlier parallel study in Europe.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me